Matthew Fraser Ahearn Sells 14,186 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 14,186 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $20.99, for a total value of $297,764.14. Following the transaction, the chief operating officer directly owned 244,176 shares in the company, valued at $5,125,254.24. This trade represents a 5.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Monday, August 17th, Matthew Fraser Ahearn sold 8,314 shares of Shoulder Innovations stock. The stock was sold at an average price of $20.10, for a total value of $167,111.40.
• On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.84, for a total transaction of $78,072.96.
• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total transaction of $296,190.08.

Shoulder Innovations Price Performance

Shoulder Innovations stock opened at $22.98 on Thursday. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $24.59. The stock has a market cap of $478.46 million and a P/E ratio of -11.97. The company has a 50-day moving average price of $20.82 and a 200 day moving average price of $16.43. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12.

Shoulder Innovations (NYSE:SI) last posted its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. Sell-side analysts anticipate that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Hedge Funds Weigh In On Shoulder Innovations

Hedge funds have recently bought and sold shares of the company. Roubaix Capital LLC boosted its holdings in Shoulder Innovations by 61.9% during the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after acquiring an additional 98,305 shares during the period. Sectoral Asset Management Inc. lifted its position in shares of Shoulder Innovations by 14.4% during the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after purchasing an additional 62,153 shares in the last quarter. KCM Capital Inc acquired a new stake in shares of Shoulder Innovations during the first quarter worth about $509,000. Blue Trust Inc. purchased a new position in shares of Shoulder Innovations in the first quarter valued at approximately $228,000. Finally, CM Management LLC acquired a new position in shares of Shoulder Innovations in the fourth quarter valued at approximately $358,000.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on SI. UBS Group upped their price target on Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Weiss Ratings upgraded shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, August 3rd. BTIG Research increased their target price on shares of Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Piper Sandler reiterated an “overweight” rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. Six research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $23.50.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.